Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Standard Chartered Bank unveils a major automation plan with a 15% cut to back-office roles as it pivots to AI-driven...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
USD Private unveils a closed digital asset platform featuring a programmed price path from $1 to $1 million over four...
BrokerBot has closed a fresh seed round led by Grand Ventures and Second Century Ventures as the AI platform scales t...
Sarah Jessica Parker’s journey from a large, struggling family to a $200 million fortune highlights how grit and ambi...
IBM unveils a groundbreaking 0.7nm nanostack in a research setting, reiterating it will not become a chipmaker. The m...
From a kitchen studio to a coveted CEO audience, this profile traces how David Senra built podcast influence by leani...
A billionaire places a bold personal bet on a private space company. This article breaks down what that move means fo...
Publicly traded crypto firms rose 23% in the first half of 2026 while crypto assets declined 36%, widening the gap to...
Base's move away from the OP Stack sent shockwaves through the crypto market. This article explains why optimism plun...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...